Obstetrics & gynaecology

Ondansetron in pregnancy not linked to most birth defects

(HealthDay)—Use of ondansetron for the treatment of nausea and vomiting in pregnancy does not appear to be associated with birth defects, according to research published in the August issue of Obstetrics & Gynecology.

Medications

Drug interaction identified for ondansetron, tramadol

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

Obstetrics & gynaecology

No risks to pregnancy seen with morning sickness drug

(HealthDay)—A drug commonly used to treat severe cases of morning sickness does not appear to be linked to birth defects or other risks to the baby, a large new study suggests.

Medications

FDA: Zofran 32-mg dose pulled from market

(HealthDay)—The 32-mg, single intravenous dose of Zofran (ondansetron), an anti-nausea drug, is being removed from the market due to its potential to cause serious, even fatal, cardiac damage, according to a Drug Safety ...

page 1 from 1